Literature DB >> 24998414

Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice.

Juan Jose Ramos-Rodriguez1, Oscar Ortiz-Barajas1, Carlos Gamero-Carrasco1, Pablo Romero de la Rosa1, Carmen Infante-Garcia1, Nuria Zopeque-Garcia2, Alfonso M Lechuga-Sancho3, Monica Garcia-Alloza4.   

Abstract

Age remains the main risk factor for developing Alzheimer's disease (AD) although certain metabolic alterations, including prediabetes and hyperinsulinemia, also increase this risk. We present a mouse model of AD (APPswe/PS1dE9 mouse) with severe hyperinsulinemia induced by long-term high fat diet (HFD) treatment. After 23 weeks on HFD learning and memory processes were compromised. We observed a significant increase in tau hyperphosphorylation and Aβ pathology, including Aβ levels and amyloid burden. Microglia activation was also significantly increased in HFD-treated mice, both in close proximity to and far from senile plaques. Insulin degrading enzyme and neprilysin levels were not affected, suggesting that Aβ degradation pathways were preserved, whereas we detected an increase in spontaneous cortical bleeding that could underlay an impairment of Aβ interstitial fluid drainage, contributing to the increase in Aβ deposition in APP/PS1-HFD mice. Altogether our data suggest that early hyperinsulinemia is enough to exacerbate AD pathology observed in APP/PS1 mice, and supports the role of insulin-resistance therapies to stop or delay central complications associated.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid-β; Haemorrhage; Hyperinsulinemia; Insulin degrading enzyme; Microglia; Neprilysin; Prediabetes; Tau

Mesh:

Substances:

Year:  2014        PMID: 24998414     DOI: 10.1016/j.psyneuen.2014.06.005

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  19 in total

Review 1.  Role of insulin resistance in Alzheimer's disease.

Authors:  Zhiyou Cai; Ming Xiao; Liying Chang; Liang-Jun Yan
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

2.  Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease.

Authors:  Jennifer M Walker; Shilpy Dixit; Anjelica C Saulsberry; James M May; Fiona E Harrison
Journal:  Neurobiol Dis       Date:  2017-01-17       Impact factor: 5.996

Review 3.  Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.

Authors:  Geert Jan Biessels; Florin Despa
Journal:  Nat Rev Endocrinol       Date:  2018-10       Impact factor: 43.330

4.  Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels.

Authors:  Henry H Ruiz; Tiffany Chi; Andrew C Shin; Claudia Lindtner; Wilson Hsieh; Michelle Ehrlich; Sam Gandy; Christoph Buettner
Journal:  Alzheimers Dement       Date:  2016-02-28       Impact factor: 21.566

5.  Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease.

Authors:  Dmitry Petrov; Melani Luque; Ignacio Pedrós; Miren Ettcheto; Sonia Abad; Mercè Pallàs; Ester Verdaguer; Carme Auladell; Jaume Folch; Antoni Camins
Journal:  Mol Neurobiol       Date:  2015-11-12       Impact factor: 5.590

6.  Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer's Disease.

Authors:  Juan Jose Ramos-Rodriguez; Tara Spires-Jones; Amy M Pooler; Alfonso Maria Lechuga-Sancho; Brian J Bacskai; Monica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2016-05-14       Impact factor: 5.590

Review 7.  Can insulin signaling pathways be targeted to transport Aβ out of the brain?

Authors:  Milene Vandal; Philippe Bourassa; Frédéric Calon
Journal:  Front Aging Neurosci       Date:  2015-06-16       Impact factor: 5.750

8.  Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.

Authors:  Elysse M Knight; Henry H Ruiz; Soong Ho Kim; Jessica C Harte; Wilson Hsieh; Charles Glabe; William L Klein; Alan D Attie; Christoph Buettner; Michelle E Ehrlich; Sam Gandy
Journal:  Acta Neuropathol Commun       Date:  2016-02-25       Impact factor: 7.801

9.  Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer's disease in metabolically stressed APPswe/PS1dE9 mice.

Authors:  Miren Ettcheto; Elena Sánchez-Lopez; Amanda Cano; Marina Carrasco; Katherine Herrera; Patricia R Manzine; Triana Espinosa-Jimenez; Oriol Busquets; Ester Verdaguer; Jordi Olloquequi; Carme Auladell; Jaume Folch; Antoni Camins
Journal:  Cell Biosci       Date:  2021-07-22       Impact factor: 7.133

Review 10.  Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.

Authors:  Bhumsoo Kim; Eva L Feldman
Journal:  Exp Mol Med       Date:  2015-03-13       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.